ClearPoint Neuro, Inc.
CLPT
$14.70
$0.412.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.61% | -3.43% | 37.49% | 26.08% | -5.34% |
| Total Depreciation and Amortization | 11.08% | 17.02% | 36.58% | 74.91% | 177.12% |
| Total Amortization of Deferred Charges | -100.00% | 57.14% | 0.00% | 7.14% | 7.14% |
| Total Other Non-Cash Items | 0.84% | -6.35% | -23.30% | -3.62% | 85.71% |
| Change in Net Operating Assets | 57.95% | 149.36% | 30.36% | 12.69% | 749.62% |
| Cash from Operations | -6.33% | 33.24% | 47.43% | 32.39% | 61.86% |
| Capital Expenditure | -1,152.38% | 94.89% | -- | -- | 46.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -101.42% |
| Cash from Investing | -39.89% | 94.89% | -- | -- | -101.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -36.98% | -- | -8.28% | -- | -13.51% |
| Repurchase of Common Stock | -127.03% | 32.97% | -66.23% | -2,920.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -76.13% | -10,956.04% | -32.49% | 321,160.00% | -30.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.21% | -431.20% | -153.68% | 309.74% | -113.50% |